Who owns Braveheart Bio, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BRVE from SEC Form 13F filings across 64 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 64 institutions disclosed 73.4M shares of Braveheart Bio, Inc. worth $1.48B — about 141% of shares outstanding; the largest disclosed holder is FCPM III SERVICES B.V.. Source: SEC Form 13F filings, parsed by EvidInvest.
64
13F holders
$1.48B
value, 2026 filers
141%
of shares outstanding (73.4M sh)
64
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BRVE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FCPM III SERVICES B.V.NEW | 21.8M | $440.9M | 41.6% | 41.9% | new |
| 2 | ORBIMED ADVISORS LLCNEW | 12.2M | $245.9M | 4.5% | 23.4% | new |
| 3 | a16z Capital Management, L.L.C.NEW | 10.2M | $206.7M | 1.0% | 19.6% | new |
| 4 | FMR LLCNEW | 7.6M | $153.2M | 0.0% | 14.6% | new |
| 5 | Frazier Life Sciences Management, L.P.NEW | 5.3M | $106.4M | 2.6% | 10.1% | new |
| 6 | ENAVATE SCIENCES GP, LLCNEW | 3.7M | $74.2M | 26.5% | 7.1% | new |
| 7 | Capital International InvestorsNEW | 1.3M | $26.3M | 0.0% | 2.5% | new |
| 8 | Avoro Capital Advisors LLCNEW | 1.3M | $25.4M | 0.3% | 2.4% | new |
| 9 | Capital Research Global InvestorsNEW | 1.0M | $20.9M | 0.0% | 2% | new |
| 10 | BlackRock, Inc.NEW | 1.0M | $20.3M | 0.0% | 1.9% | new |
| 11 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 992,741 | $20.1M | 0.0% | 1.9% | new |
| 12 | EVENTIDE ASSET MANAGEMENT, LLCNEW | 910,000 | $18.4M | 0.3% | 1.7% | new |
| 13 | RA CAPITAL MANAGEMENT, L.P.NEW | 565,000 | $11.4M | 0.1% | 1.1% | new |
| 14 | Woodline Partners LPNEW | 502,718 | $10.2M | 0.0% | 1% | new |
| 15 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/NEW | 465,251 | $9.4M | 0.0% | 0.9% | new |
| 16 | Nextech Invest Ltd.NEW | 416,700 | $8.4M | 0.4% | 0.8% | new |
| 17 | EcoR1 Capital, LLCNEW | 416,700 | $8.4M | 0.4% | 0.8% | new |
| 18 | Casdin Capital, LLCNEW | 400,000 | $8.1M | 0.4% | 0.8% | new |
| 19 | Pivotal bioVenture Partners Investment Advisor LLCNEW | 317,351 | $6.4M | 2.5% | 0.6% | new |
| 20 | T. Rowe Price Investment Management, Inc.NEW | 310,097 | $6.3M | 0.0% | 0.6% | new |
| 21 | GEODE CAPITAL MANAGEMENT, LLCNEW | 288,798 | $5.8M | 0.0% | 0.6% | new |
| 22 | FARALLON CAPITAL MANAGEMENT, L.L.C.NEW | 277,778 | $5.6M | 0.0% | 0.5% | new |
| 23 | UBS Group AGNEW | 229,072 | $4.6M | 0.0% | 0.4% | new |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 146,453 | $3.0M | 0.0% | 0.3% | new |
| 25 | VANGUARD FIDUCIARY TRUST CONEW | 139,247 | $2.8M | 0.0% | 0.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.